Chronic kidney disease (CKD) imposes a large burden on patients and families and the US healthcare system as well. Approximately one out of seven US adults has CKD. In 2019, Medicare fee-for-service beneficiaries with CKD had an all-cause...
Read more
Today, consumers make decisions every year about whether to renew or change health plans. Exchange-based multi-year plans would have to overcome significant obstacles before they become reality, but they hold the potential for helping the United...
Read more
Not all devices are created equal. But how can device manufacturers identify the low-hanging fruit for a risk-sharing arrangement? Needless to say, the more characteristics a product has that are associated with successful risk-sharing...
Read more
As the U.S. healthcare system becomes increasingly value-oriented, we are seeing a relatively new phenomenon—the increased use of risk-sharing arrangements between manufacturers and providers or payers, where payments for devices are tied to...
Read more
In June 2019, Louisiana contracted with Asegua Therapeutics––a subsidiary of Gilead Sciences––to pay a lump sum in exchange for as much of a new hepatitis C regimen as is needed to treat patients in its Medicaid program and correction facilities...
Read more